Jingsun Wei

636 total citations · 1 hit paper
22 papers, 394 citations indexed

About

Jingsun Wei is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jingsun Wei has authored 22 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Jingsun Wei's work include Genetic factors in colorectal cancer (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Ferroptosis and cancer prognosis (5 papers). Jingsun Wei is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Ferroptosis and cancer prognosis (5 papers). Jingsun Wei collaborates with scholars based in China, Iran and United Kingdom. Jingsun Wei's co-authors include Kefeng Ding, Qian Xiao, Dongliang Fu, Kai Jiang, Yang Tang, Xiaoxu Ge, Xiangxing Kong, Siqi Dai, Liubo Chen and Chenhan Zhong and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Jingsun Wei

21 papers receiving 393 citations

Hit Papers

Identification of novel protein biomarkers and drug targe... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingsun Wei China 9 192 145 103 77 50 22 394
Linfei Hu China 13 268 1.4× 119 0.8× 104 1.0× 68 0.9× 43 0.9× 34 451
Catia Lippolis Italy 13 165 0.9× 128 0.9× 138 1.3× 62 0.8× 41 0.8× 19 476
Asmitananda Thakur China 15 356 1.9× 198 1.4× 91 0.9× 73 0.9× 69 1.4× 25 507
Shibo Yu China 10 175 0.9× 124 0.9× 92 0.9× 112 1.5× 42 0.8× 26 367
Jiong Yang China 9 244 1.3× 132 0.9× 81 0.8× 60 0.8× 46 0.9× 14 415
Junmei Jia China 13 182 0.9× 96 0.7× 83 0.8× 44 0.6× 53 1.1× 30 336
Shuijie Li China 13 248 1.3× 139 1.0× 96 0.9× 40 0.5× 91 1.8× 31 466
Xi Cheng China 12 348 1.8× 232 1.6× 143 1.4× 56 0.7× 66 1.3× 18 531

Countries citing papers authored by Jingsun Wei

Since Specialization
Citations

This map shows the geographic impact of Jingsun Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingsun Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingsun Wei more than expected).

Fields of papers citing papers by Jingsun Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingsun Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingsun Wei. The network helps show where Jingsun Wei may publish in the future.

Co-authorship network of co-authors of Jingsun Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jingsun Wei. A scholar is included among the top collaborators of Jingsun Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingsun Wei. Jingsun Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Yimin, Haiyan Chen, Kai Jiang, et al.. (2025). NUPR1 Promotes Radioresistance in Colorectal Cancer Cells by Inhibiting Ferroptosis. Journal of Cellular and Molecular Medicine. 29(7). e70519–e70519.
2.
Wei, Jingsun, Xiaoxu Ge, Kai Jiang, et al.. (2024). Development and verification of a combined immune- and cancer-associated fibroblast related prognostic signature for colon adenocarcinoma. Frontiers in Immunology. 15. 1291938–1291938. 6 indexed citations
3.
Tang, Yang, Jingsun Wei, Xiaoxu Ge, et al.. (2024). Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer. Cancer Letters. 588. 216798–216798. 5 indexed citations
4.
Sun, Jing, Jianhui Zhao, Jingsun Wei, et al.. (2024). Plasma proteomic and polygenic profiling improve risk stratification and personalized screening for colorectal cancer. Nature Communications. 15(1). 8873–8873. 12 indexed citations
5.
Yang, Hangsheng, Jiafeng Wang, Xinyi Zhou, et al.. (2024). Impact of protein corona and PEGylation on the accumulation and efficacy of lysosome-disrupting lipid nanoparticles in KRAS-mutated cancer. Nano Today. 56. 102307–102307. 5 indexed citations
6.
Sun, Jing, Jianhui Zhao, Fangyuan Jiang, et al.. (2023). Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome. Genome Medicine. 15(1). 75–75. 91 indexed citations breakdown →
7.
Zhou, Xinyi, Dongliang Fu, Hang Yang, et al.. (2023). Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells. Cancer Letters. 577. 216422–216422. 11 indexed citations
8.
Hu, Yeting, et al.. (2021). The Disulfiram/Copper Complex Induces Autophagic Cell Death in Colorectal Cancer by Targeting ULK1. Frontiers in Pharmacology. 12. 752825–752825. 40 indexed citations
9.
Jiang, Kai, Haiyan Chen, Liubo Chen, et al.. (2021). Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness. Journal of Experimental & Clinical Cancer Research. 40(1). 21–21. 91 indexed citations
10.
Wei, Jingsun, Wei Lu, Fangfang Sun, et al.. (2021). Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer. Frontiers in Genetics. 12. 619611–619611. 11 indexed citations
11.
12.
Wei, Jingsun, Yang Tang, Xiaoxu Ge, et al.. (2021). Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma. OncoTargets and Therapy. Volume 14. 413–426. 5 indexed citations
13.
Chen, Yuetong, Cuiju Tang, Xiaowei Wei, et al.. (2020). Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer. Medicine. 99(25). e20809–e20809. 4 indexed citations
14.
Tang, Yang, Qian Xiao, Yue Liu, et al.. (2020). Increased RAB31 Expression in Cancer-Associated Fibroblasts Promotes Colon Cancer Progression Through HGF-MET Signaling. Frontiers in Oncology. 10. 1747–1747. 27 indexed citations
15.
Wei, Jingsun, Yuetong Chen, Junfeng Shi, et al.. (2019). Identification of biomarkers and their functions in dasatinib‑resistant pancreatic cancer using bioinformatics analysis. Oncology Letters. 18(1). 197–206. 6 indexed citations
16.
Chen, Yuetong, Yang Gong, Jingsun Wei, et al.. (2019). The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for metastatic colorectal cancer. Medicine. 98(39). e17384–e17384. 6 indexed citations
17.
Chu, Xia, Xinying Huo, Jingsun Wei, et al.. (2019). Establishment and characterization of a novel cell line (cc‑006cpm8) of moderately/poorly differentiated colorectal adenocarcinoma derived from a primary tumor of a patient. International Journal of Oncology. 55(1). 243–256. 1 indexed citations
18.
Wei, Jingsun, Honghong Zhang, Xia Chu, et al.. (2018). Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients. Cancer Management and Research. Volume 10. 1429–1437. 5 indexed citations
19.
Shi, Junfeng, Yi Chen, Wenxing Chen, et al.. (2018). Isobavachalcone sensitizes cells to E2‐induced paclitaxel resistance by down‐regulating CD44 expression in ER+ breast cancer cells. Journal of Cellular and Molecular Medicine. 22(11). 5220–5230. 20 indexed citations
20.
Wei, Jingsun, Xinying Huo, Yang Gong, et al.. (2018). Establishment and Characterization of gc-006-03, a Novel Human Signet Ring Cell Gastric Cancer Cell Line Derived from Metastatic Ascites. Journal of Cancer. 9(18). 3236–3246. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026